The antidepressant -like effects of delta-opioid receptor agonists
- PMID: 16809477
- DOI: 10.1124/mi.6.3.7
The antidepressant -like effects of delta-opioid receptor agonists
Abstract
Activation of the delta-opioid receptor (DOR) system produces an interesting behavioral profile distinct from that of other opioids. Unlike mu- and kappa-opioid agonists, delta-opioid agonists alone have limited pain-relieving qualities as measured in morphine-sensitive antinociceptive assays. Recent evidence, however, suggests that the DOR system may play a role in regulating mood and emotional states. For example, DOR activation stimulates robust antidepressant-like effects in preclinical assays, suggesting that these compounds may have therapeutic potential for treating human depression. This review discusses the role of the DORs in depression and the antidepressant-like effects of delta-opioid agonists as well as their limitations.
Similar articles
-
Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.Psychopharmacology (Berl). 2002 Oct;164(1):42-8. doi: 10.1007/s00213-002-1179-y. Epub 2002 Jul 30. Psychopharmacology (Berl). 2002. PMID: 12373418
-
Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways.J Physiol Pharmacol. 2010 Jun;61(3):355-62. J Physiol Pharmacol. 2010. PMID: 20610867
-
Discovery of δ opioid receptor full agonists lacking a basic nitrogen atom and their antidepressant-like effects.Bioorg Med Chem Lett. 2020 Jun 15;30(12):127176. doi: 10.1016/j.bmcl.2020.127176. Epub 2020 Apr 8. Bioorg Med Chem Lett. 2020. PMID: 32299730
-
Delta Opioid Receptors and Modulation of Mood and Emotion.Handb Exp Pharmacol. 2018;247:179-197. doi: 10.1007/164_2017_42. Handb Exp Pharmacol. 2018. PMID: 28993835 Review.
-
Behavioral effects of delta-opioid receptor agonists: potential antidepressants?Jpn J Pharmacol. 2002 Sep;90(1):1-6. doi: 10.1254/jjp.90.1. Jpn J Pharmacol. 2002. PMID: 12396021 Review.
Cited by
-
Inflammatory pain is enhanced in delta opioid receptor-knockout mice.Eur J Neurosci. 2008 May;27(10):2558-67. doi: 10.1111/j.1460-9568.2008.06223.x. Epub 2008 May 29. Eur J Neurosci. 2008. PMID: 18513322 Free PMC article.
-
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.J Med Chem. 2008 Mar 27;51(6):1817-23. doi: 10.1021/jm7014765. Epub 2008 Mar 1. J Med Chem. 2008. PMID: 18311909 Free PMC article.
-
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.J Med Chem. 2019 Jan 24;62(2):561-574. doi: 10.1021/acs.jmedchem.8b01158. Epub 2019 Jan 11. J Med Chem. 2019. PMID: 30608693 Free PMC article.
-
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.Br J Pharmacol. 2007 Dec;152(8):1312-24. doi: 10.1038/sj.bjp.0707497. Epub 2007 Nov 5. Br J Pharmacol. 2007. PMID: 17982482 Free PMC article.
-
Allostery at opioid receptors: modulation with small molecule ligands.Br J Pharmacol. 2018 Jul;175(14):2846-2856. doi: 10.1111/bph.13823. Epub 2017 Jun 7. Br J Pharmacol. 2018. PMID: 28419415 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials